Chi Steve Chan – Chairman & CEO, Adimmune Corporation, Taiwan
Adimmune Corporation is the only influenza vaccine manufacturer with both EU GMP and US FDA certification in Asia,…
Founded in 22nd December 1965, Adimmune Corporation principally engages in R&D, manufacture and sale of vaccines and medicines. Production base is in Tanzi, Taichun. The important well-known product is H1N1 vaccine. IPO issued in Forth January 2010. Our main product is the influenza vaccine. The main product of this company, influenza vaccine, is provided to public in Taiwan by Sanofi-Aventis, Novartis and Glaxo Smith Kline (GSK). Major raw materials are the liquid, syringes, and mice.
Adimmune Corporation is the only influenza vaccine manufacturer with both EU GMP and US FDA certification in Asia,…
The president of Adimmune Corporation discusses how the avian flu outbreak of 2006/2007 changed the course of the…
Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s…
Johnsee Lee and Eric Yang of Taiwanese precision medicine diagnostics firm Quark Biosciences outline their…
Louis Cheng, CEO of Taiwanese firm Leadgene Biomedical, introduces the company’s expertise in antibody…
Taiwan Bio Industry Organization Chairman Dr Johnsee Lee outlines the Taiwanese biopharmaceutical industry’s…
Taiwan, although small in size, boasts a strong culture of innovation as well as a universal healthcare system that…
Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an…
While Taiwanese pharmaceutical and biotech players have traditionally set their sights on the US as a key market,…
All country managers of multinational pharma companies need to strike the balance between having a global outlook…
Nutrarex Biotech is a Taiwanese private label contract manufacturer of functional supplements, exclusively…
In an effort to enhance trade and cooperation with other countries in the region and reduce dependency on mainland…
Within Taiwan’s evolving medical device sector, many innovative startups are exploring breakthrough ideas which…
Mark Yang, CEO of GaleMed, elaborates on the medical device manufacturer’s transition from a privately-owned…